Cases 21 - 30 of 129
Purdue Pharma L.P. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv01155
Plaintiff:
Purdue Pharma L.P. , Purdue Pharmaceuticals L.P. , The P.F. Laboratories, Inc. and others
Defendant:
Mylan Pharmaceuticals Inc. and Mylan, Inc.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al
as 2:2015cv08180
Defendant:
MYLAN PHARMACEUTICALS, INC., MYLAN INC., ACTAVIS LLC and others
Plaintiff:
VALEANT PHARMACEUTICALS INTERNATIONAL, INC., PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC. and others
Cause Of Action: 35 U.S.C. § 271
AstraZeneca LP et al v. Mylan Inc et al
as 1:2015cv00999
Plaintiff:
AstraZeneca LP , AstraZeneca AB , AstraZeneca UK Limited and others
Defendant:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Noven Pharmaceuticals, Inc. v. Mylan Technologies Inc. et al
as 1:2015cv00979
Plaintiff:
Noven Pharmaceuticals, Inc.
Defendant:
Mylan Technologies Inc. , Mylan Pharmaceuticals Inc. , Mylan N.V. and others
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Inc. et al
as 1:2015cv00960
Plaintiff:
Pfizer Inc. , Wyeth LLC , Pfizer Pharmaceuticals LLC and others
Defendant:
Mylan Inc., Mylan N.V., Mylan Laboratories Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Fresenius Kabi USA, LLC et al v. Mylan Laboratories Limited et al
as 1:2015cv00942
Plaintiff:
Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GmbH
Defendant:
Mylan Laboratories Limited, Mylan Inc., Agila Specialties Inc. and others
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al
as 1:2015cv00902
Plaintiff:
Bayer Intellectual Property GMBH , Bayer Pharma AG and Janssen Pharmaceuticals Inc.
Defendant:
Aurobindo Pharma Limited , Aurobindo Pharma USA Inc. , Breckenridge Pharmaceutical Inc. and others
Counter_claimant:
Sigmapharm Laboratories LLC and Prinston Pharmaceutical Inc.
Counter_defendant:
Bayer Intellectual Property GMBH , Bayer Pharma AG and Janssen Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al
as 1:2015cv07009
Plaintiff:
ASTRAZENECA PHARMACEUTICALS LP , ASTRAZENECA UK LIMITED and ASTRAZENECA AB
Defendant:
MYLAN PHARMACEUTICALS INC. , MYLAN INC. and MYLAN LABORATORIES LIMITED
Cause Of Action: 35 U.S.C. § 271
Janssen Pharmaceutica, N.V. et al v. Mylan Pharmaceuticals, Inc. et al
as 1:2015cv00760
Plaintiff:
Janssen Pharmaceutica, N.V. , Janssen Sciences Ireland UC , Gilead Sciences Ireland UC and others
Defendant:
Mylan Pharmaceuticals, Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al
as 3:2015cv05982
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. , BOEHRINGER INGELHEIM INTERNATIONAL GMBH , BOEHRINGER INGELHEIM CORPORATION and others
Defendant:
HEC PHARM GROUP , HEC PHARM CO., LTD. , HEC PHARM USA and others
Counter_claimant:
SUN PHARMACEUTICAL INDUSTRIES, INC. , SUN PHARMACEUTICAL INDUSTRIES LTD. , SUN PHARMA GLOBAL FZE and others
Counter_defendant:
BOEHRINGER INGELHEIM CORPORATION , BOEHRINGER INGELHEIM INTERNATIONAL GMBH , BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
